Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients

Background. We evaluated the utility of galactomannan (GM) in bronchoalveolar lavage fluid (BALF) for the diagnosis of invasive pulmonary aspergillosis (IPA) in nonneutropenic patients. Methods. A total of 183 patients were included in the final analysis. Bronchoscopies and the detection of GM in BA...

Full description

Saved in:
Bibliographic Details
Main Authors: Qidong Zhuang, Hongying Ma, Yun Zhang, Lei Chen, Li Wang, Lin Zheng, Zaichun Deng, Zhongbo Chen
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2017/3685261
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562893102514176
author Qidong Zhuang
Hongying Ma
Yun Zhang
Lei Chen
Li Wang
Lin Zheng
Zaichun Deng
Zhongbo Chen
author_facet Qidong Zhuang
Hongying Ma
Yun Zhang
Lei Chen
Li Wang
Lin Zheng
Zaichun Deng
Zhongbo Chen
author_sort Qidong Zhuang
collection DOAJ
description Background. We evaluated the utility of galactomannan (GM) in bronchoalveolar lavage fluid (BALF) for the diagnosis of invasive pulmonary aspergillosis (IPA) in nonneutropenic patients. Methods. A total of 183 patients were included in the final analysis. Bronchoscopies and the detection of GM in BALF were all performed on them. Results. Ten cases of IPA were diagnosed. ROC data demonstrated that, for diagnosing IPA, an optimal cutoff value for GM in BALF of 0.76 yielded a sensitivity of 100.0% and a specificity of 76.2%. Symptoms and radiological findings had no significant difference between proven or probable IPA group and non-IPA group. In our case-control analysis, although nine patients with false-positive results received treatment with Piperacillin/tazobactam, there was no significant difference between case and control group. Conclusions. BALF GM detection is a valuable adjunctive diagnostic tool. Our retrospective study suggests that the optimal value of GM detection in BALF is 0.76 in nonneutropenic patients.
format Article
id doaj-art-99e2c73649424ebeabf26a66d80052bd
institution Kabale University
issn 1198-2241
1916-7245
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Canadian Respiratory Journal
spelling doaj-art-99e2c73649424ebeabf26a66d80052bd2025-02-03T01:21:28ZengWileyCanadian Respiratory Journal1198-22411916-72452017-01-01201710.1155/2017/36852613685261Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic PatientsQidong Zhuang0Hongying Ma1Yun Zhang2Lei Chen3Li Wang4Lin Zheng5Zaichun Deng6Zhongbo Chen7Department of Pulmonology, The Affiliated Hospital of Ningbo University, 247 Renmin Road, Ningbo, Zhejiang 315020, ChinaDepartment of Pulmonology, The Affiliated Hospital of Ningbo University, 247 Renmin Road, Ningbo, Zhejiang 315020, ChinaDepartment of Pulmonology, The Affiliated Hospital of Ningbo University, 247 Renmin Road, Ningbo, Zhejiang 315020, ChinaDepartment of Pulmonology, The Affiliated Hospital of Ningbo University, 247 Renmin Road, Ningbo, Zhejiang 315020, ChinaDepartment of Microbiology, The Affiliated Hospital of Ningbo University, 247 Renmin Road, Ningbo, Zhejiang 315020, ChinaDepartment of Microbiology, The Affiliated Hospital of Ningbo University, 247 Renmin Road, Ningbo, Zhejiang 315020, ChinaDepartment of Pulmonology, The Affiliated Hospital of Ningbo University, 247 Renmin Road, Ningbo, Zhejiang 315020, ChinaDepartment of Pulmonology, The Affiliated Hospital of Ningbo University, 247 Renmin Road, Ningbo, Zhejiang 315020, ChinaBackground. We evaluated the utility of galactomannan (GM) in bronchoalveolar lavage fluid (BALF) for the diagnosis of invasive pulmonary aspergillosis (IPA) in nonneutropenic patients. Methods. A total of 183 patients were included in the final analysis. Bronchoscopies and the detection of GM in BALF were all performed on them. Results. Ten cases of IPA were diagnosed. ROC data demonstrated that, for diagnosing IPA, an optimal cutoff value for GM in BALF of 0.76 yielded a sensitivity of 100.0% and a specificity of 76.2%. Symptoms and radiological findings had no significant difference between proven or probable IPA group and non-IPA group. In our case-control analysis, although nine patients with false-positive results received treatment with Piperacillin/tazobactam, there was no significant difference between case and control group. Conclusions. BALF GM detection is a valuable adjunctive diagnostic tool. Our retrospective study suggests that the optimal value of GM detection in BALF is 0.76 in nonneutropenic patients.http://dx.doi.org/10.1155/2017/3685261
spellingShingle Qidong Zhuang
Hongying Ma
Yun Zhang
Lei Chen
Li Wang
Lin Zheng
Zaichun Deng
Zhongbo Chen
Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients
Canadian Respiratory Journal
title Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients
title_full Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients
title_fullStr Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients
title_full_unstemmed Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients
title_short Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients
title_sort galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis with nonneutropenic patients
url http://dx.doi.org/10.1155/2017/3685261
work_keys_str_mv AT qidongzhuang galactomannaninbronchoalveolarlavagefluidfordiagnosisofinvasivepulmonaryaspergillosiswithnonneutropenicpatients
AT hongyingma galactomannaninbronchoalveolarlavagefluidfordiagnosisofinvasivepulmonaryaspergillosiswithnonneutropenicpatients
AT yunzhang galactomannaninbronchoalveolarlavagefluidfordiagnosisofinvasivepulmonaryaspergillosiswithnonneutropenicpatients
AT leichen galactomannaninbronchoalveolarlavagefluidfordiagnosisofinvasivepulmonaryaspergillosiswithnonneutropenicpatients
AT liwang galactomannaninbronchoalveolarlavagefluidfordiagnosisofinvasivepulmonaryaspergillosiswithnonneutropenicpatients
AT linzheng galactomannaninbronchoalveolarlavagefluidfordiagnosisofinvasivepulmonaryaspergillosiswithnonneutropenicpatients
AT zaichundeng galactomannaninbronchoalveolarlavagefluidfordiagnosisofinvasivepulmonaryaspergillosiswithnonneutropenicpatients
AT zhongbochen galactomannaninbronchoalveolarlavagefluidfordiagnosisofinvasivepulmonaryaspergillosiswithnonneutropenicpatients